|
1）Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116: 281-97
|
|
|
|
2）Didiano D, Hobert O. Perfect seed pairing is not a generally reliable predictor for miRNA-target interactions. Nat Struct Mol Biol. 2006; 13: 849-51
|
|
|
|
|
|
3）Navarro F, Lieberman J. Small RNAs guide hematopoietic cell differentiation and function. J Immunol. 2010; 184: 5939-47
|
|
|
|
|
|
4）Lu J, Guo S, Ebert BL, et al. MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors. Dev Cell. 2008; 14: 843-53
|
|
|
|
|
|
5）Barroga CF, Pham H, Kaushansky K. Thrombopoietin regulates c-Myb expression by modulating micro RNA 150 expression. Exp Hematol. 2008; 36: 1585-92
|
|
|
|
|
|
6）Adams BD, Guo S, Bai H, et al. An in vivo functional screen uncovers miR-150-mediated regulation of hematopoietic injury response. Cell Rep. 2012; 2: 1048-60
|
|
|
|
|
|
7）Navarro F, Gutman D, Meire E, et al. Existence of a microRNA pathway in anucleate platelets. Nat Struct Mol Biol. 2009; 16: 961-6
|
|
|
|
|
|
8）Edelstein LC, McKenzie SE, Shaw C, et al. MicroRNAs in platelet production and activation. J Thromb Haemost. 2013; 11: 340-50
|
|
|
|
|
|
9）Xu X, Gnatenko DV, Ju J, et al. Systematic analysis of microRNA fingerprints in thrombocythemic platelets using integrated platforms. Blood. 2012; 120: 3575-85
|
|
|
|
|
|
10）Bruchova H, Merkerova M, Prchal JT. Aberrant expression of microRNA in polycythemia vera. Haematologica. 2008; 93: 1009-16
|
|
|
|
|
|
11）Kondkar AA, Bray MS, Leal SM, et al. VAMP8/endobrevin is overexpressed in hyperreactive human platelets: suggested role for platelet microRNA. J Thromb Haemost. 2010; 8: 369-78
|
|
|
|
|
|
12）Edelstein LC, Simon LM, Montoya RT, et al. Racial differences in human platelet PAR4 reactivity reflect expression of PCTP and miR-376c. Nat Med. 2013; 19: 1609-16
|
|
|
|
|
|
13）Zampetaki A, Willeit P, Tilling L, et al. Prospective study on circulating microRNAs and risk of myocardial infarction. J Am Coll Cardiol. 2012; 60: 290-9
|
|
|
|
|
|
14）Sondermeijer BM, Bakker A, Halliani A, et al. Platelets in patients with premature coronary artery disease exhibit upregulation of miRNA340* and miRNA624*. PLoS One. 2011; 6: e25946
|
|
|
|
|
|
15）Georgantas RW 3rd, Hildreth R, Morisot S, et al. CD34＋ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc Natl Acad Sci U S A. 2007; 104: 2750-5
|
|
|
|
|
|
16）Navarro F, Gutman D, Meire E, et al. miR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53. Blood. 2009; 114: 2181-92
|
|
|
|
|
|
17）Ichimura A, Ruike Y, Terasawa K, et al. MicroRNA-34a inhibits cell proliferation by repressing mitogen-activated protein kinase kinase 1 during megakaryocytic differentiation of K562 cells. Mol Pharmacol. 2010; 77: 1016-24
|
|
|
|
|
|
18）Opalinska JB1, Bersenev A, Zhang Z, et al. MicroRNA expression in maturing murine megakaryocytes. Blood. 2010; 116: e128-38
|
|
|
|
|